Shimada S - Search Results

1

Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization.

Fujino H, Yamada I, Shimada S, Yoneda M, Kojima J. Fujino H, et al. Among authors: shimada s. Xenobiotica. 2003 Jan;33(1):27-41. doi: 10.1080/0049825021000017957. Xenobiotica. 2003. PMID: 12519692

2

Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: similarities and difference in the metabolism of pitavastatin in monkeys and humans.

Yamada I, Fujino H, Shimada S, Kojima J. Yamada I, et al. Among authors: shimada s. Xenobiotica. 2003 Jul;33(7):789-803. doi: 10.1080/0049825031000121635. Xenobiotica. 2003. PMID: 12893526

3

Simultaneous determination of taxol and its metabolites in microsomal samples by a simple thin-layer chromatography radioactivity assay--inhibitory effect of NK-104, a new inhibitor of HMG-CoA reductase.

Fujino H, Yamada I, Shimada S, Yoneda M. Fujino H, et al. Among authors: shimada s. J Chromatogr B Biomed Sci Appl. 2001 Jun 5;757(1):143-50. doi: 10.1016/s0378-4347(01)00141-4. J Chromatogr B Biomed Sci Appl. 2001. PMID: 11419739

4

Disopyramide concentrations in human plasma and saliva: comparison of disopyramide concentrations in saliva and plasma unbound concentrations.

Sagawa K, Mohri K, Shimada S, Shimizu M, Muramatsu J. Sagawa K, et al. Among authors: shimada s. Eur J Clin Pharmacol. 1997;52(1):65-9. doi: 10.1007/s002280050250. Eur J Clin Pharmacol. 1997. PMID: 9143870 Clinical Trial.

5

Comparative pharmacodynamics of eight calcium channel blocking agents in Japanese essential hypertensive patients.

Shimada S, Nakajima Y, Yamamoto K, Sawada Y, Iga T. Shimada S, et al. Biol Pharm Bull. 1996 Mar;19(3):430-7. doi: 10.1248/bpb.19.430. Biol Pharm Bull. 1996. PMID: 8924914

6

In vitro-in vivo correlation of pharmacodynamics of felodipine in essential hypertensive patients based on an ion-channel binding model.

Nakajima Y, Yamamoto K, Shimada S, Kotaki H, Sawada Y, Iga T. Nakajima Y, et al. Among authors: shimada s. Biol Pharm Bull. 1996 Aug;19(8):1097-9. doi: 10.1248/bpb.19.1097. Biol Pharm Bull. 1996. PMID: 8874826

7

Fas/Fas ligand-mediated elimination of antigen-bearing Langerhans cells in draining lymph nodes.

Kawamura T, Azuma M, Kayagaki N, Shimada S, Yagita H, Okumura K. Kawamura T, et al. Among authors: shimada s. Br J Dermatol. 1999 Aug;141(2):201-5. doi: 10.1046/j.1365-2133.1999.02965.x. Br J Dermatol. 1999. PMID: 10468788

8

Inactivation of (1-->3)-beta-D-glucan in mice.

Miura T, Ohno N, Suda M, Miura NN, Shimada S, Yadomae T. Miura T, et al. Among authors: shimada s. Biol Pharm Bull. 1995 Dec;18(12):1797-1801. doi: 10.1248/bpb.18.1797. Biol Pharm Bull. 1995. PMID: 8787813

9

[Therapeutic effects of beclomethasone dipropionate enemas on colon damage of inflammatory bowel disease model rats].

Shimada S, Aoyama T, Shibuya F, Nakajima K, Kotaki H, Sawada Y, Iga T. Shimada S, et al. Yakugaku Zasshi. 1998 Jun;118(6):216-25. doi: 10.1248/yakushi1947.118.6_216. Yakugaku Zasshi. 1998. PMID: 9629057 Japanese.

10

Direct induction of tetraploids or homozygous diploids in the industrial yeast Saccharomyces cerevisiae by hydrostatic pressure.

Hamada K, Nakatomi Y, Shimada S. Hamada K, et al. Among authors: shimada s. Curr Genet. 1992 Nov;22(5):371-6. doi: 10.1007/BF00352438. Curr Genet. 1992. PMID: 1423724

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results